Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
In connection with the offering, Adicet entered into a stock purchase agreement with certain existing investors for
The shares are being offered by Adicet pursuant to a shelf registration statement that was previously filed with, and subsequently declared effective on
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Investor and Media Contacts
Stern Investor Relations, Inc.
Source: Adicet Bio